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Overexpression of Helicard, a CARD-
Containing Helicase Cleaved during
Apoptosis, Accelerates DNA Degradation
human cells may express more than 50 different heli-
cases [8]. These estimates are largely based on the
presence of seven highly conserved motifs identified in
most known helicases (see below). Recent studies have
shown that helicases, via DNA twisting, have also an
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Chemin des Boveresses 155 effect on chromatin remodeling [9]. This activity can
alter the position of nucleosomes along DNA, transferCH-1066 Epalinges
Switzerland histone octamers from one DNA fragment to another,
and thus modulates the access of transcription factors2 MEMOREC Stoffel GmbH
Stoeckheimer Weg 1 to DNA.
In proapoptotic signaling pathways, the interactionD-50829 Koeln
Germany between the different initiator units, such as the death
receptor Fas, the various adaptor proteins, and cas-
pases is primarily mediated by three structurally related
protein-protein domains called death domain (DD),Summary
death effector domain (DED), and caspase-recruitment
domain (CARD) [10]. Therefore, to identify novel candi-Apoptotic cell death is characterized by several morpho-
date proteins that are implicated in proapoptotic signal-logical nuclear changes, such as chromatin condensa-
ing pathways, we screened public databases with ation and extensive fragmentation of chromosomal DNA
generalized profile of CARD motifs from all currently[1]. These alterations are primarily triggered through
known CARD sequences [11]. Several hitherto noniden-the activation of caspases, which subsequently cleave
tified CARD-containing proteins were found, one ofnuclear substrates. Caspase-3 induces processing of
which particularly attracted our attention, since, in addi-Acinus, which leads to chromatin condensation [2].
tion to the CARD domain, it also contained a predictedDNA fragmentation is dependent on the DNase CAD,
helicase domain. The corresponding full-length cDNAwhich is released from its inhibitor, ICAD, upon cleav-
was cloned via a combination of available EST clonesage by caspase-3 [3]. DNA degradation is also induced
and RT-PCR. The predicted murine protein has 1025by AIF [4] and endonuclease G [5, 6], which are both
amino acids and contains at the amino-terminal regionreleased from mitochondria upon death stimuli but
two CARD domains (Figures 1A and 1B) followed by ado not require prior processing by caspases for their
region showing high homology to helicases (Figure 1C).DNase activity. Here we report the identification of a
We refer to this novel protein as Helicard. Most of thewidely expressed helicase designated Helicard, which
helicases contain seven characteristic motifs in a regioncontains two N-terminal CARD domains and a C-ter-
of 300–500 residues. The DECH sequence found in motifminal helicase domain. Upon apoptotic stimuli, Heli-
II of Helicard indicates that it is a member of the DExH-card is cleaved by caspases, thereby separating the
box subfamily of RNA and DNA helicases. The corre-CARD domains from the helicase domain. While Heli-
sponding human homolog shows extensive sequencecard localizes in the cytoplasm, the helicase-con-
homology (84% identical aa, data not shown). Databasetaining fragment is found in the nucleus. Helicard ac-
searches revealed that proteins with a similar overallcelerates Fas ligand-mediated DNA degradation,
structure exist in human (RIG1), pig (RIG1), and C. ele-whereas a noncleavable or a helicase-dead Helicard
gans (F15B10.2), indicating that Helicards are evolution-mutant does not, implicating Helicard in the nuclear
ary highly conserved. The expression of RIG1 is upregu-remodeling occurring during apoptosis.
lated by retoinic acids, but its function is not known [12].
Given the homology of Helicard with helicases, we
Results and Discussion tested Helicard for its helicase activity using an indirect
method, based on the ATPase activity of helicases [13].
DNA and RNA helicases are a ubiquitous and diverse We expressed the helicase domain of Helicard (aa 252–
group of enzymes defined by their capacity to catalyze 1025) and found that the recombinant protein exhibited
the unwinding of duplex nucleic acid molecules [7]. They an ATPase activity which was triggered by RNA and to
participate in multiple cellular processes, including DNA a lesser extent by DNA (Figure 2D).
replication, DNA repair, recombination, transcription, By Northern blot analysis, Helicard was found to be
transcriptional regulation, RNA processing, and transla- widely expressed as a 4.4 kb transcript, with prominent
tion. In fact, in every process involving the manipulation expression in lung, liver, kidney, heart, and spleen (Fig-
of nucleic acids, helicases play important roles. The ure 2E). Using a polyclonal antibody raised against the
diversity of functions in which helicases operate is re- CARD domains of Helicard, the expression pattern was
flected in the number of different helicases present in confirmed at the protein level. In addition to the 140
prokaryotic and eukaryotic cells. Escherichia coli con- kDa full-length protein, most tissues examined also con-
tains at least 12 biochemically distinct helicases, and tained a reactive band migrating at around 45 kDa.
Although we cannot rule out the presence of an alterna-
tively spliced form of Helicard, it is more likely that the3 Correspondence: jurg.tschopp@ib.unil.ch
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Figure 1. Characterization and Expression of Helicard
(A) Predicted amino acid sequence and schematic representation of murine Helicard, which contains two CARD motifs and a helicase domain
linked by an intermediate region of 100 amino acids.
(B) Alignment of the two CARD domains of human and murine Helicard with CARD motifs present in the Helicard related proteins RIG1 and
C. elegans F15B10.2 and in various other proteins implicated in apoptosis. Black boxes indicate a greater than 50% amino acid sequence
identity, and gray boxes indicate greater than 50% amino acid similarity through conservative amino acid substitution.
(C) Alignment of the helicase domains of human and murine Helicard with the helicase domains of human and pig RIG1, C. elegans F15B10.2,
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Figure 2. Helicard Is Cleaved in Cells Undergoing Apoptosis
(A) Cleavage of Helicard upon FasL induced apoptosis. (Left panel) 293T cells were transfected with cDNA encoding the Flag-tagged full-
length Helicard and stimulated for the indicated time with FasL (200 ng/ml). Cell lysates were subsequently analyzed by Western blot analysis
using an anti-Flag-antibody. (Middle panel) Cleavage of Helicard upon TRAIL stimulation. 293T cells were transfected and stimulated for 3 hr
with TRAIL (100 ng/ml). (Right panel) Apoptosis was induced with staurosporine (Stau, 1 g/ml). Note the presence of a fragment (F) of 45
kDa, even in the absence of proapoptotic stimuli.
(B) Cleavage of endogenous Helicard in murine A20 B lymphomas undergoing Fas-mediated apoptosis. A20 cells, either sensitive (S) or
resistant (R) to FasL, were treated with 200 ng/ml of FasL and harvested at the indicated times. Cell extracts were analyzed by Western blot
analysis using either an anti-Helicard antibody or a monoclonal antibody recognizing the cleaved form of PARP as an indicator of apoptosis.
(C) Caspase inhibition prevents FasL-induced cleavage of Helicard. 293 T cells were transfected with full-length Helicard cDNA. Thirty min
before FasL stimulation, the indicated caspase inhibitors were added at given concentrations. Cells were then incubated with FasL (200 ng/ml) for
3 hr and analyzed as in (A).
(D) Identification of Helicard cleavage sites. 293T cells were transfected with either the wild-type, 200-221, D208, or the D251 mutants of
Helicard and stimulated for 3 hr with FasL (200 ng/ml).
Werner helicase, Xeroderma Pigmentosum B and D helicase, Bloom helicase, and Cockayne helicase. The seven motifs that are characteristic
for helicases are indicated. Numbers between motifs refer to aa separating the motifs. The highly conserved DExH box required for ATP
binding is indicated.
(D) ATPase activity of helicase activity. ATPase activity of 293T supernatants containing recombinant Helicard (helicase-containing fragment)
was measured in the presence of murine DNA or RNA or with no nucleic acid. For control purposes, supernatants of nontransfected cells
were assayed. Oxidation of NADH, which is directly proportional to the rate of ATP hydrolysis, was continuously monitored by measuring the
absorbance at 338 nm. Means  standard errors of a represenative experiment are shown. The experiment has been repeated three times.
(E) Expression of Helicard RNA in various murine tissues. A Northern blot of various mouse tissues (Clontech) was probed with a 32P-labeled
antisense RNA fragment covering the CARD-coding region of Helicard. The blot was subsequently hybridized with a -actin probe.
(F) Western blot analysis of various murine tissues. A blot containing 50 g of protein extracted from the indicated cells was probed with an
anti-Helicard antibody, directed toward the N-terminal portion of the protein. The blot was reprobed with anti-tubulin to demonstrate equal
loading.
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band corresponds to a proteolytic cleavage product (see
below).
We considered a role of Helicard in apoptosis in view
of the presence of CARD domains. When 293T cells
were transiently transfected with an expression vector
encoding Helicard, not only the full-length Helicard (140
kDa) protein but also frequently a fragment of 45 kDa,
which corresponds in size to the fragment seen in tis-
sues (see Figure 1E), was detectable (Figure 2A). Upon
FasL stimulation, Helicard was processed into three ad-
ditional N-terminal cleavage products. At 60 min after
FasL addition, a 41 kDa fragment was detectable, fol-
lowed by the appearance of fragments of 28 and 30 kDa,
respectively. Similar data were obtained when TRAIL,
another cytotoxic ligand of the TNF superfamily, was
used to induce apoptosis (Figure 2A). Moreover, stauro-
sporine, which via its kinase inhibitory activity triggers
apoptosis through the mitochondrial pathway [14], in-
duced processing of Helicard, indicating that pro-
cessing of Helicard occurs upon activation of both major
proapoptotic pathways. Processing of endogenous Hel-
icard is shown in Figure 2B, where, in the murine A20
B lymphoma cell, the full-length Helicard was cleaved
into fragments of 45 kDa and 28–30 kDa (Figure 2B).
Interestingly, an additional fragment of 120 kDa was
generated. While this latter cleavage was predicted to
occur after the helicase domain, all other processing
events were calculated to take place in the intermediate
domain, which separates the CARD domains from the
helicase domain. The generation of these fragments was
caspase dependent, as it was inhibited by z-VAD-fmk,
a pan-caspase inhibitor (data not shown). Using more
Figure 3. Subcellular Distribution of Helicard
selective caspase-inhibitors (for caspase-8, IETD-fmk,
HeLa cells were transfected with expression plasmids for Flag-and for caspase 3, DEVD-fmk), we found that in cells tagged full-length Helicase or Flag-tagged fragments encoding ei-
preincubated with IETD-fmk the generation of all frag- ther the CARD or the helicase domains, and their subcellular local-
ments was completely blocked, while DEVD-fmk inhib- ization was determined 30 hr after transfection by confocal laser
microscopy, using anti-Flag antibodies. The overlay of Helicard fluo-ited preferentially the production of the 30 and 28 kDa
rescence (green) and nuclear staining (PI, red) is shown in yellowfragments (Figure 2C). This suggested that upon induc-
(Merge).tion of apoptosis by FasL, the initial cleavage of Helicard
(41 kDa) might be caspase-8-dependent, while subse-
quent cleavage events might be induced by caspase-3.
fragment (aa 252–1025) was found to be localized inMapping studies supported this notion (Figure 2D). The
the nucleus. These immunostaining data suggest that thecleavage sites responsible for the generation of the 41
helicase-containing fragment, once liberated from thekDa (SCTD251) and the 28 kDa (DNTD208) fragments lie
CARD domains, translocates from the cytoplasm intowithin typical caspase-8 and caspase-3 recognition
the nucleus.sites, respectively. Interestingly, the failure of caspases
Since the helicase domain-containing fragment ofto cleave at Asp251 also blocked the generation of the
Helicard was localized in the nucleus, we next testedsmaller Helicard fragments, suggesting that initial pro-
whether the Helicard had any effect on nuclear DNAcessing at Asp251 is a prerequisite for further cleavage
degradation. We adopted a protocol used to character-events. We also mapped the cleavage sites responsible
ize the ICAD/CAD complex [3]. Cell extracts were iso-for the generation of the 30 kDa and the 45 kDa fragment
lated from Bjab B lymphoma cells, treated or not withseen in tissues and upon overexpression to Asp 216
FasL for 3 hr, and added to nuclei purified from rat liver.and to the region between aa 260 and 280, respectively
In agreement with previous results [15], caspase-3 found(Figure 2 and data not shown).
in apoptotic cell extracts from FasL-treated cells acti-To test whether the cleavage of Helicard in apoptotic
vated CAD, giving rise to the typical DNA ladder (Figurecells had an impact on its subcellular localization, we
4A). In contrast, no DNA degradation was induced byperformed confocal microscopy (Figure 3). Immuno-
nonapoptotic cell extracts. We next added supernatantsstaining of HeLa cells transfected with low amounts of
of 293T cells that had been transfected with a secretedfull-length Helicard revealed a cytoplasmic staining. A
form of the helicase domain of Helicard (aa 252–1025,cytoplasmic staining was also observed when cells were
a signal peptide was added N-terminally to induce se-transfected with an expression plasmid corresponding
cretion) or, as control, with the empty vector. The pres-to the fragment containing the two CARD domains (aa
1–278). In contrast, the helicase-containing C-terminal ence of Helicard in the supernatant had no accelerating
effect on DNA degradation when added to cell extracts
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was specific, since supernatants of mock-transfected
293T cells were inactive.
We next transfected 293T cells with an expression
vector containing the full-length Helicard, with the
cleavage-resistant D251 Helicard mutant, or with a control
plasmid. Upon addition of FasL, DNA laddering was
measured (Figure 4B). In mock-transfected cells, DNA
degradation was detectable 3 hr after FasL addition. In
the presence of exogenous Helicard, DNA degradation
was already noticeable 2 hr after ligand addition, coin-
ciding with the caspase-mediated processing of Heli-
card. In contrast, the D251 Helicard mutant, which was not
cleaved upon FasL stimulation, was unable to accelerate
DNA degradation (Figure 4B). DNA degradation was also
not accelerated with a Helicard that was mutated in the
DExH box (E→A). This mutant form is predicted to not
bind ATP and therefore to have no helicase activity (Fig-
ure 4B). Thus, the observed sensitization to DNA degra-
dation by Helicard is dependent on the helicase activity
and on processing by caspases.
Helicard is a novel, highly conserved helicase whose
ATPase activity can be stimulated by RNA and less po-
tently by DNA. The physiological function of Helicard,
of the related RIG1, and of the C. elegans homolog is
currently not known. We found that Helicard is cleaved
in apoptotic cells and that the processed protein signifi-
cantly sensitizes cells to DNA degradation. Although
the exact mode of action is unknown, it is tempting to
speculate that Helicard is activated upon binding to a
CARD-containing protein that binds to one of the CARD
domains of Helicard. We tested more than 15 CARD-
containing proteins and found no interaction partner,
suggesting that Helicard’s CARD associates with a hith-Figure 4. Helicard Accelerates DNA Fragmentation
erto uncharacterized CARD protein. CARD binding may(A) DNA fragmentation induced by Helicard and apoptotic cell ex-
then allow the access of caspases to the intermediatetracts. Human Bjab B cells were incubated at 37C for 3 hr with ()
domain. The helicase domain, once freed from the CARDor without () FasL before preparing cell extracts. Nuclei from rat
normal liver cells were then incubated for the indicated periods of domains, then translocates from the cytoplasm to the
time with the respective cell extracts (6 mg/ml) in the presence nucleus where it acts on chromatin architecture. This
or absence of the recombinant helicase domain of Helicard. DNA could allow a more easy access of CAD, thereby acceler-
degradation of the treated nuclei was then analyzed by agarose gel ating the degradation of the genomic DNA.
electrophoresis.
Finally, it is noteworthy that helicases are mutated in(B) 293T cells were transiently transfected with expression vectors
several diseases [8]. Bloom’s syndrome, characterizedencoding either wild-type, D251A mutant (resistant to caspase
by dwarfism; Werner’s syndrome, an autosomal reces-cleavage), or E444A mutant (deficient in ATP binding) of Helicard,
as indicated, or empty vector. Transfected cells were then stimu- sive disease leading to premature aging; and -Thalas-
lated with FasL (200 ng/ml) for various periods of time. Cells were semia mental retardation on the X chromosome (ATR-X),
lysed, and the cytosolic extract was analyzed by Western blot for whose clinical features are severe mental retardation,
Helicard cleavage (upper two panels) and by agarose gel electro- are three examples where the defective gene has been
phoresis (lower panel) for DNA degradation.
mapped to genes that encode a helicase. Although the
physiological function of the respective helicases is
poorly defined, there is evidence that the helicase defec-
from FasL-treated cells (data not shown). However, tive in ATR-X controls chromatin accessibility [8]. Inacti-
when recombinant Helicard-containing supernatants vation of helicases through mutation may therefore re-
were added to nonapoptotic cell extracts, DNA fragmen- sult in delayed apoptosis, and indeed, p53-mediated
tation was spontaneously induced. Although experi- apoptosis appears to be attenuated in Werner’s syn-
mental evidence is currently lacking, we favor the possi- drome cells [16]. This may explain why patients with
bility that the low amount of CAD generated by small Werner’s and Bloom’s syndrome have a high predisposi-
quantities of active caspases present in the “nonapo- tion for cancer. Thus, control of apoptosis may be added
to the many biological processes in which helicases areptotic” cell extracts (compared to apoptotic cell ex-
known to play crucial roles.tracts, caspase-3 activity was nine times lower; data not
shown) suffices to trigger DNA degradation, provided
Experimental Proceduresthat CAD is assisted by Helicard. Recombinant Helicard
was unable to induce DNA cleavage in the absence of Cloning of Murine Helicard cDNA
cellular extracts, indicating that Helicard has no DNase EST clones encoding murine Helicard were identified in the dbEST
database using a generalized profile method based on sequenceactivity on its own. The sensitizing effect of Helicard
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homology among other CARD-containing proteins [17]. All EST M., et al. (1999). Molecular characterization of mitochondrial
apoptosis-inducing factor. Nature 397, 441–446.clones found lacked the 3	 end; therefore, a RACE PCR was per-
formed on murine cDNA. 5. Li, L.Y., Luo, X., and Wang, X. (2001). Endonuclease G is an
apoptotic DNase when released from mitochondria. Nature 412,
95–99.Expression Vectors
6. Parrish, J., Li, L., Klotz, K., Ledwich, D., Wang, X., and Xue, D.cDNA encoding the various tagged-Helicard proteins or fragments
(2001). Mitochondrial endonuclease G is important for apoptosiswere amplified by standard polymerase chain reaction methods
in C. elegans. Nature 412, 90–94.using Pwo polymerase (Boehringer Mannheim) and specific primers
7. Eisen, A., and Lucchesi, J.C. (1998). Unraveling the role of heli-containing suitable restriction sites on 5	 end on cDNA template.
cases in transcription. Bioessays 20, 634–641.Amplified products were cloned into pCR-O-blunt (Invitrogen) and
8. Ellis, N.A. (1997). DNA helicases in inherited human disorders.sequenced. Subcloning into expression vectors derived from pCR-3
Curr. Opin. Genet. Dev. 7, 354–363.(Invitrogen) yielded expression constructs with an N-terminal or
9. Flaus, A., and Owen-Hughes, T. (2001). Mechanisms for ATP-C-terminal FLAG tag. Helicard lacking amino acids 200–221 (Heli-
dependent chromatin remodelling. Curr. Opin. Genet. Dev. 11,card200-221), point mutants of Helicard (Asp251Ala, Asp208Ala,
148–154.Asp216Ala), were obtained by amplification on cloned full-length
10. Hofmann, K. (1999). The modular nature of apoptotic signalingmurine Helicard. In the Helicard ATP binding mutant, Glu was re-
proteins. Cell. Mol. Life Sci. 55, 1113–1128.placed with Ala at position 444 in the Helicard DExH box.
11. Hofmann, K., Bucher, P., and Tschopp, J. (1997). The CARD
domain: a new apoptotic signalling motif. Trends Biochem. Sci.Transient Cell Transfection
22, 155–156.293T cells were seeded at 1–2 
 106 cells per 10 cm plates and
12. Huang, S.L., Shyu, R.Y., Yeh, M.Y., and Jiang, S.Y. (2000). Clon-transfected the next day by the calcium phosphate precipitation
ing and characterization of a novel retinoid-inducible gene 1method. The precipitate was left on cells for 8 hr, and cells were
(RIG1) deriving from human gastric cancer cells. Mol. Cell. Endo-collected 26–30 hr after transfection. Fas ligand stimulation was
crinol. 159, 15–24.carried out using a 293 T clone sensitive to Fas ligand. Cells were
13. Iost, I., Dreyfus, M., and Linder, P. (1999). Ded1p, a DEAD-stimulated with cross-linked FasL (200 ng/ml, purchased from Apo-
box protein required for translation initiation in Saccharomycestech) for various periods of time. When indicated, caspase inhibitors
cerevisiae, is an RNA helicase. J. Biol. Chem. 274, 17677–17683.(purchased from Alexis) were added 30 min before the addition of
14. Green, D.R., and Reed, J.C. (1998). Mitochondria and apoptosis.Fas ligand.
Science 281, 1309–1312.
15. Enari, M., Hase, A., and Nagata, S. (1995). Apoptosis by a cyto-Cell Lysis, Western Blot Analysis, and Confocal Microscopy
solic extract from Fas-activated cells. EMBO J. 14, 5201–5208.These techniques were performed essentially as described pre-
16. Spillare, E.A., Robles, A.I., Wang, X.W., Shen, J.C., Yu, C.E.,viously [18–20]). Cellular Helicard (endogenous) was detected using
Schellenberg, G.D., and Harris, C.C. (1999). p53-mediated apo-an affinity-purified polyclonal antibody (AL180) directed against the
ptosis is attenuated in Werner syndrome cells. Genes Dev. 13,recombinant CARD domain of Helicard (aa 2–208), Flag-tagged pro-
1355–1360.teins with the anti-Flag antibody M2 (Sigma).
17. Bucher, P., Karplus, K., Moeri, N., and Hofmann, K. (1996). A
flexible search technique based on generalized profiles. Com-ATPase Assay
put. Chem. 20, 3–24.ATPase activity was measured as described previously [13]. Briefly,
18. Bodmer, J.L., Burns, K., Schneider, P., Hofmann, K., Steiner,the method uses pyruvate kinase and lactate deshydrogenase to
V., Thome, M., Bornand, T., Hahne, M., Schroter, M., Becker,link hydrolysis of ATP to oxidation of NADH, which results in a
K., et al. (1997). TRAMP, a novel apoptosis-mediating receptordecrease in the absorbance at 338 nm.
with sequence homology to tumor necrosis factor receptor 1
and Fas (Apo-1/CD95). Immunity 6, 79–88.Isolation of DNA Fragments from Purified Nuclei
19. Thome, M., Martinon, F., Hofmann, K., Rubio, V., Steiner, V.,and Intact Cells
Schneider, P., Mattmann, C., and Tschopp, J. (1999). EquineRat liver nuclei, cell lysates, and DNA degradation were performed
herpesvirus-2 E10 gene product, but not its cellular homologue,as described [15, 21].
activates NF-kappaB transcription factor and c-Jun N-terminal
kinase. J. Biol. Chem. 274, 9962–9968.Acknowledgments
20. Thome, M., Gaide, O., Micheau, O., Martinon, F., Bonnet, D.,
Gonzalez, M., and Tschopp, J. (2001). Equine herpesvirus pro-This work was supported by grants of the Swiss National Science
tein E10 induces membrane recruitment and phosphorylationFoundation (to J.T. and M.K.) and the Association pour la recherche
of its cellular homologue, Bcl-10. J. Cell Biol. 152, 1115–1122.contre le cancer (ARC, to O.M.). We thank Dr. Kim Burns for useful
21. Newmeyer, D.D., and Wilson, K.L. (1991). Egg extracts for nu-comments; Severine Reynard for technical assistance; and all mem-
clear import and nuclear assembly reactions. Methods Cell Biol.bers of the Tschopp lab for their helpful thoughts.
36, 607–634.
Received: February 11, 2002
Accession Numbers
Revised: March 13, 2002
Accepted: March 22, 2002
The GenBank accession number for the murine Helicard is AY075132.
Published: May 14, 2002
References
1. Nagata, S. (2000). Apoptotic DNA fragmentation. Exp. Cell Res.
256, 12–18.
2. Sahara, S., Aoto, M., Eguchi, Y., Imamoto, N., Yoneda, Y., and
Tsujimoto, Y. (1999). Acinus is a caspase-3-activated protein
required for apoptotic chromatin condensation. Nature 401,
168–173.
3. Sakahira, H., Enari, M., and Nagata, S. (1998). Cleavage of CAD
inhibitor in CAD activation and DNA degradation during apopto-
sis. Nature 391, 96–99.
4. Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E.,
Brothers, G.M., Mangion, J., Jacotot, E., Costantini, P., Loeffler,
